Implementation and Delivery of Cabotegravir Long Acting Injection for PrEP in a Community Pharmacy Setting.
Clinical trial NCT05867212 · COMPLETED
Trial details
- NCT number
- NCT05867212
- Sponsor
- Kelley-Ross & Associates, Inc.
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2023-05-13
- Primary completion
- 2025-04-30
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.